Dental Pulp Stem Cell Culture Supernatant for Inflammatory Disease Treatment

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current treatments for inflammatory diseases such as fulminant hepatitis and interstitial pneumonia, including liver and lung transplantation, steroid therapy, and stem cell transplantation, face challenges like donor shortages, side effects, and risks of cancerous transformations, with limited effectiveness and understanding of their mechanisms.

Innovation Solution

A composition containing culture supernatant obtained by culturing dental pulp stem cells, which is serum-free and devoid of cells, is administered to treat inflammatory diseases by promoting tissue repair through immunocompetent cell differentiation, thereby addressing the limitations of existing treatments.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If organ transplantation (liver or lung) is performed to treat inflammatory diseases, then treatment effectiveness is improved, but donor availability deteriorates due to shortage

Engineering Contradiction:
Improvetreatment effectivenessVSAvoiddonor availability
Core Design Contradiction:
ReliabilityVSQuantity of substance

Solution Approach 1:

The invention extracts and utilizes only the necessary functional components (growth factors, cytokines, extracellular vesicles) from stem cells through culture supernatant, eliminating the need for whole organ transplantation while preserving therapeutic effects. This resolves the contradiction by providing treatment effectiveness without requiring donor organs.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The invention creates a functional copy of stem cell therapy effects using culture supernatant that contains secreted bioactive molecules. Instead of transplanting whole organs or stem cells, the supernatant replicates the regenerative and anti-inflammatory effects, solving the donor shortage problem while maintaining treatment effectiveness.

Inventive Principle:
Principle #26Copying

2Reliability

If steroid pulse therapy is used to treat fulminant hepatitis, then treatment effectiveness is limited, but side effects increase

Engineering Contradiction:
Improvetreatment effectivenessVSAvoidside effects
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The invention changes the therapeutic parameter from steroids to stem cell culture supernatant, which contains growth factors and cytokines that promote tissue regeneration and modulate immunity without the harmful side effects of steroids. This resolves the contradiction by providing improved effectiveness without increased side effects.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention converts the harmful inflammatory response into a beneficial regenerative process by using stem cell supernatant that contains anti-inflammatory cytokines and growth factors. These components not only reduce inflammation but also promote tissue repair, transforming the harmful inflammatory state into a beneficial regenerative state without steroid side effects.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

3Reliability

If stem cell transplantation is performed to treat inflammatory diseases, then therapeutic effects are improved, but risk of cancerous transformation increases

Engineering Contradiction:
Improvetherapeutic effectVSAvoidcancer risk
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The invention extracts only the therapeutic secretions (growth factors, cytokines, extracellular vesicles) from stem cells while leaving behind the stem cells themselves. This eliminates the risk of cancerous transformation from transplanted stem cells while preserving the therapeutic effects through the use of culture supernatant.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The invention uses culture supernatant as an intermediary that carries the therapeutic information and bioactive molecules from stem cells to the diseased tissue without requiring direct transplantation of stem cells. This intermediary approach maintains therapeutic effectiveness while eliminating the safety risks associated with live stem cell transplantation.

Inventive Principle:
Principle #24Intermediary (Mediator)

4Adaptability or versatility

If conventional therapies are used for interstitial pneumonia, then treatment options are limited, but complexity of treatment increases

Engineering Contradiction:
Improvetreatment optionsVSAvoidtreatment complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The invention uses stem cell culture supernatant that provides multiple therapeutic functions simultaneously: anti-inflammatory effects, immunomodulation, and tissue regeneration. This single multi-functional treatment replaces multiple conventional therapies, increasing adaptability while reducing treatment complexity.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The dental pulp stem cell culture supernatant effectively prevents or treats inflammatory diseases by reducing inflammation, improving survival rates, and promoting tissue regeneration without the drawbacks of traditional therapies, such as organ transplantation and hormone therapies.

Implementation Method 1

promoting tissue repair through immunocompetent cell differentiation

Methodology Applied
Scientific EffectCell differentiation:

Implementation Method 2

promoting tissue regeneration

Methodology Applied
Scientific EffectTissue regeneration:

Data Source

PatentUS10709741B2Composition for preventing or treating inflammatory disease
Publication Date: 2020.07.14 SHED TECH CORPORATION
  • US10709741B2 patent drawing
  • US10709741B2 patent drawing
  • US10709741B2 patent drawing

AI summary

A composition for preventing or treating inflammatory disease and that is effective for inflammatory disease such as fulminant hepatitis and interstitial pneumonia. For such an objective, the present uses a culture supernatant obtained by culturing dental pulp stem cells as the active ingredient of the composition for preventing or treating inflammatory disease.